Anavex Life Sciences Corp. (AVXL) vs NervGen Pharma Corp. Common stock (NGEN)
A side-by-side comparison of Anavex Life Sciences Corp. and NervGen Pharma Corp. Common stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVXL
Anavex Life Sciences Corp.
$1.64HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
NGEN
NervGen Pharma Corp. Common stock
$1.81HealthcareDelayed quote: Oct 6, 2026, 12:06 PM EDT
Total return — AVXL vs NGEN
growth of $100 · dividends reinvested · last 1yAVXL -62.9% (-62.9%/yr)NGEN -57.6% (-57.6%/yr)NGEN compounded faster over this window
AVXL NGEN
AVXL vs NGEN: by the numbers
- •AVXL is the larger company ($152M vs $148M market cap).
Metrics side by side
Valuation
| Metric | AVXL | NGEN |
|---|---|---|
| P/B ratio | 1.35 | 12.18 |
Profitability
| Metric | AVXL | NGEN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -21.38% | -397.38% |
| ROIC | -27.25% | -223.90% |
Growth (annualized)
| Metric | AVXL | NGEN |
|---|---|---|
| Total return CAGR (5Y) | -37.74% | N/A |
Go deeper
Dig into the metrics
Anavex Life Sciences ROENervGen Pharma Corp. Common stock ROEAnavex Life Sciences operating marginNervGen Pharma Corp. Common stock operating marginAnavex Life Sciences revenue growthNervGen Pharma Corp. Common stock revenue growthAnavex Life Sciences free cash flowNervGen Pharma Corp. Common stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.